Skip to main content

Guardian Pharmacy Services, Inc.

corporate_fare Company Profile

Guardian Pharmacy Services, Inc.

GRDN·NYSE·Trade & Services·CIK 0001802255

Guardian Pharmacy Services is a leading pharmacy services company providing technology-enabled services to residents of long-term care facilities (LTCFs). The company focuses on helping residents adhere to their drug regimens to reduce care costs and improve clinical outcomes. Guardian emphasizes individualized clinical, drug dispensing, and administration capabilities tailored for residents in historically lower acuity LTCFs, specifically assisted living facilities (ALFs) and behavioral health facilities and group homes (BHFs). Over two-thirds of Guardian's annual revenue for each of the past three years came from residents of ALFs and BHFs, with the remainder primarily from skilled nursing facilities (SNFs). As of December 31, 2025, Guardian operated 61 pharmacies, 54 of which are full-service, serving approximately 205,000 residents in approximately 8,400 LTCFs across 38 states. The company addresses challenges in ALFs and BHFs, such as residents being on various pharmacy benefit plans with distinct formularies and reimbursement processes, and ALFs often lacking staff with formal clinical training, on-site medical directors, or full-time nurses.

Guardian Pharmacy Services, Inc. (NYSE:GRDN) is a publicly traded company in the Trade & Services sector. Wiseek has independently scored 30 items for GRDN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for GRDN spans SCHEDULE 13D/A, 8-K, 10-Q, DEF 14A.

Recent high-impact activity:

  • Guardian Pharmacy Lifts FY26 EBITDA Outlook to $136-138M After 24% Q3 EBITDA Growth
  • Guardian Pharmacy Class B Converts to Class A, Insider Group Holds 43.9%
  • Guardian Pharmacy Acquires Nautilus Assets, Expanding LTC Footprint to 14 States
  • Guardian Pharmacy Raises 2026 Guidance After Strong Q2, Net Income Surges on Settlement
  • Guardian Pharmacy Services Acquires Wellness Concepts, Expanding Virginia Operations

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.45B
Net Income
$49.22M
Op. Cash Flow
$100.25M
Free Cash Flow
$86.84M
Gross Profit
$292.72M
Operating Income
$72.7M
Cash & Equivalents
$65.62M
Total Debt
$0
Debt / Equity
0.00×
Net Margin
3.4%
Source: 10-K · filed 2026-03-11 · accession 0001193125-26-102172

Short Interest & Short Volume

6.64 days to cover

FINRA reported short interest of 2,204,814 shares in GRDN as of the October 30, 2026 settlement, a 7.5% decrease from the prior period — about 6.6 days to cover at its recent average daily volume. On November 20, 2026, 62.0% of GRDN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,204,814 shares as of October 30, 2026
Change vs prior period▼ 7.5%
Days to cover6.64 at avg daily volume of 332,004
Daily short volume (FINRA facilities)62.0% of 198,591 shares on November 20, 2026
5-day average short volume62.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with G →
$46.94
52-week range · as of 2026-09-28 $23.14 – $48.33
Market cap
$2.97B
Volume
526.7K (1.1× avg)
3-mo avg 488.2K
Live data · 2026-11-21 23:07 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed GRDN - Latest Insights

GRDN
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $39.87
Real-time Price: $46.94 info
Change: +$7.07 (+18%) info
Market Cap: $2.974B info
GRDN
Sep 28, 2026, 5:02 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $40.74
Real-time Price: $46.94 info
Change: +$6.20 (+15%) info
Market Cap: $2.974B info
GRDN
Sep 01, 2026, 4:30 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $38.60
Real-time Price: $46.94 info
Change: +$8.34 (+22%) info
Market Cap: $2.974B info
GRDN
Aug 06, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $39.47
Real-time Price: $46.94 info
Change: +$7.47 (+19%) info
Market Cap: $2.974B info
GRDN
Jul 01, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $42.13
Real-time Price: $46.94 info
Change: +$4.81 (+11%) info
Market Cap: $2.974B info
GRDN
Jun 22, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $41.30
Real-time Price: $46.94 info
Change: +$5.64 (+14%) info
Market Cap: $2.974B info
GRDN
May 28, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $38.75
Real-time Price: $46.94 info
Change: +$8.19 (+21%) info
Market Cap: $2.974B info
GRDN
May 28, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.75
Real-time Price: $46.94 info
Change: +$8.19 (+21%) info
Market Cap: $2.974B info
GRDN
May 06, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $32.00
Real-time Price: $46.94 info
Change: +$14.94 (+47%) info
Market Cap: $2.974B info
GRDN
May 06, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $36.58
Real-time Price: $46.94 info
Change: +$10.36 (+28%) info
Market Cap: $2.974B info
GRDN
Mar 26, 2026, 7:18 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $36.86
Real-time Price: $46.94 info
Change: +$10.08 (+27%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 6:17 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
GRDN
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $37.57
Real-time Price: $46.94 info
Change: +$9.37 (+25%) info
Market Cap: $2.974B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets